Physicians' Academy for Cardiovascular Education

Inflammation and anti-inflammatory therapy in CVD

10' education - Apr. 11, 2022 - Prof. Thomas Lüscher, MD - London, UK and Zürich, Switzerland

Video navigation menu

  • A historical overview on inflammation in atherosclerosis 0:28
  • Why do coronary arteries occlude? The role of inflammation 2:59
  • Anti-inflammatory therapies in CVD  7:09
  • Anti-inflammatory therapy in rheumatoid arthritis  12:00
  • Summary 13:05


Show transcript

Educational information

This presentation by Thomas Lüscher is part of a series titled "Inflammation: The next therapeutic frontier in targeting cardiovascular risk". This series consists of an introduction, three lectures and a discussion in which four experts in this field will bring you up to date on the role of inflammation in atherosclerosis and how to translate findings from science and clinical trials into practice.


Professor Thomas Lüscher is affiliated with the Royal Brompton and Harefield Hospitals and Imperial College, London, UK and Center for Molecular Cardiology at the Universität Zürich, Switzerland.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant received from Novo Nordisk. A/S


This educational activity is intended for an international audience of non-US and non-UK HCPs

Listen to the podcast View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: